Treatment of anxiety disorders in patients with comorbid bipolar disorder
Mental Health Clinician · 01.11.2018 · 8 (6) · 256-263
DOI: 10.9740/mhc.2018.11.256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Clinician, erschienen am 01.11.2018. Verfasst von Carol A Ott. Beteiligte Einrichtung: (Corresponding author) Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis,…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Anxiety disorders are the most prevalent comorbid diagnoses in patients with bipolar disorder (BD). A comorbid anxiety diagnosis can significantly impact the severity of bipolar symptoms, increase the risk of suicidality, and decrease psychosocial functioning and quality of life. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force published recommendations for treatment in 2012 suggesting that specific anticonvulsant mood stabilizers and second-generation antipsychotics are the medications of choice to treat these comorbidities. Serotonergic antidepressant medications are first-line medications for the treatment of most anxiety disorders; however, this can be problematic for a patient with BD. Antidepressant use in BD has been associated with a risk of manic switch as well as potential destabilization of mood. Mood stabilizer therapy should be established for patients with comorbid BD and an anxiety disorder before other medications are added to address the anxiety disorder. While benzodiazepine medications are recommended as third-line therapy in the CANMAT task force recommendations, their use should be avoided in patients with comorbid BD, posttraumatic stress disorder, and substance use disorders. The use of benzodiazepines should in general be avoided for all patients if possible, based upon current clinical research. Interpersonal, cognitive behavioral, and relaxation therapy are effective for the treatment of anxiety symptoms, especially emotional experiences, in patients who are euthymic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- (Corresponding author) Clinical Professor of Pharmacy Practice, Department of Pharmacy Practice, Purdue University College of Pharmacy, Indianapolis, Indiana; Clinical Pharmacy Specialist, Outpatient Psychiatry, Prevent…
ORCID-Profile: Carol A Ott
Zitieren
APA
Ott, C. A. (2018). Treatment of anxiety disorders in patients with comorbid bipolar disorder. Mental Health Clinician, 8(6), 256-263. https://doi.org/10.9740/mhc.2018.11.256
Vancouver
Ott CA. Treatment of anxiety disorders in patients with comorbid bipolar disorder. Mental Health Clinician. 2018;8(6):256-263. doi:10.9740/mhc.2018.11.256
BibTeX
@article{Ott2018,
author = {Ott, Carol A},
title = {Treatment of anxiety disorders in patients with comorbid bipolar disorder},
journal = {Mental Health Clinician},
year = {2018},
volume = {8},
number = {6},
pages = {256--263},
doi = {10.9740/mhc.2018.11.256}
}
EUVIMED